The shedding of LRP-1 is facilitated by pro-inflammatory cytokines [38] or atherogenic lipoproteins [143], resulting in its soluble form (sLRP-1) which can be measured in the circulation; sLRP-1 was decreased in OSA and correlated with disease severity [144]. The gene discussed is LRP1; the disease is obstructive sleep apnea syndrome.